Edoxaban impurity 4是 Edoxaban 的一种杂质。Edoxaban 是一种口服的选择性和有效的因子 Xa (FXa) 抑制剂，用于预防中风。

NP-313是一种有效的抗血栓剂，能够抑制血小板聚集与活化，具备双重抑制血栓素 A2 合成及选择性抑制 SOCC 介导的钙离子内流的能力。

Ximelagatran是一种口服活性凝血酶抑制剂，选择性和竞争性地抑制游离和凝块结合的凝血酶。该化合物具有抗凝血作用，药代动力学和药效学表现出可预测的剂量依赖性，适用于抗凝血治疗的研究。

Heparin Lithium salt是一种有效的抗凝剂，通过与抗凝血酶 III (ATIII) 可逆结合来增强抗凝活性，显著抑制外泌体与细胞的相互作用，广泛用于血栓预防和相关研究。

Heparin sodium salt (Sodium heparin) 是一种抗凝剂，可与抗凝血酶III (ATIII) 可逆地结合，大大加快了ATIII使凝血酶因子IIa和Xa失活的速度。Heparin sodium salt 显著抑制外泌体与细胞的相互作用。

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule.

Melagatran is a thrombin inhibitor. Melagatran prevents tissue factor expression in human platelet-monocyte heterotypic complexes. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice.

Dabigatran etexilate, the active prodrug of dabigatran, is a selective inhibitor of thrombin with Ki of 4.5 nM.

Dabigatran is a reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM.

Dabigatran ethyl ester is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity.

Dabigatran etexilate mesylate inhibits thrombin with Ki value of 4.5 nM. It is the prodrug of dabigatran.

AEBSF HCl is a irreversible inhibitor of proteases like chymotrypsin, kallikrein, plasmin, thrombin, and trypsin.

Edoxaban is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention.

Argatroban is a potent and selective synthetic thrombin inhibitor with Ki ranging from 5 nM to 39 nM, used as an anticoagulant.

Argatroban is an inhibitor of thrombin.